{
    "xml": "<topic id=\"PHP1117\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/phenoxybenzamine-hydrochloride\" basename=\"phenoxybenzamine-hydrochloride\" title=\"PHENOXYBENZAMINE HYDROCHLORIDE\">\n<title>PHENOXYBENZAMINE HYDROCHLORIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_834\" namespace=\"/interactions/list-of-drug-interactions/alpha-blockers/phenoxybenzamine\">Phenoxybenzamine</xref>\n</p>\n<data name=\"vtmid\">74771007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_658662261\" title=\"Alpha-adrenoceptor blockers\">Alpha-adrenoceptor blockers</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP36126\" outputclass=\"indicationsAndDose\" rev=\"1.36\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hypertension in phaeochromocytoma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 10&#8239;mg daily, increased in steps of 10&#8239;mg daily until hypertension controlled or treatment not tolerated; maintenance 1&#8211;2&#8239;mg/kg daily in 2 divided doses.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36144\" outputclass=\"contraindications\" rev=\"1.10\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Avoid infusion in hypovolaemia</ph>; <ph outputclass=\"contraindication\">during recovery period after myocardial infarction (usually 3&#8211;4 weeks)</ph>; <ph outputclass=\"contraindication\">history of cerebrovascular accident</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36155\" outputclass=\"cautions\" rev=\"1.19\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Cautions</title>\n<body>\r\n<section outputclass=\"cautions\">\r\n<p>\r\n<ph outputclass=\"caution\">Avoid contact with skin (risk of contact sensitisation)</ph>; <ph outputclass=\"caution\">avoid extravasation (irritant to tissues)</ph>; <ph outputclass=\"caution\">avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"caution\">carcinogenic in <i>animals</i>\r\n</ph>; <ph outputclass=\"caution\">cerebrovascular disease</ph>; <ph outputclass=\"caution\">congestive heart failure</ph>; <ph outputclass=\"caution\">elderly</ph>; <ph outputclass=\"caution\">severe ischaemic heart disease</ph>\r\n</p>\r\n </section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP36114\" outputclass=\"sideEffects\" rev=\"1.12\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Gastro-intestinal disturbances</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Inhibition of ejaculation</ph>; <ph outputclass=\"sideEffect\">lassitude</ph>; <ph outputclass=\"sideEffect\">miosis</ph>; <ph outputclass=\"sideEffect\">nasal congestion</ph>; <ph outputclass=\"sideEffect\">postural hypotension (with dizziness and marked compensatory tachycardia)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">decreased sweating (after intravenous infusion)</ph>; <ph outputclass=\"sideEffect\">dry mouth (after intravenous infusion)</ph>; <ph outputclass=\"sideEffect\">idiosyncratic profound hypotension (within few minutes of starting infusion)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">convulsions (following rapid intravenous infusion)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36121\" outputclass=\"pregnancy\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Hypotension may occur in newborn.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36160\" outputclass=\"breastFeeding\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>May be present in milk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36117\" outputclass=\"renalImpairment\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36107\" outputclass=\"monitoringRequirements\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor blood pressure regularly during infusion.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36168\" outputclass=\"directionsForAdministration\" rev=\"1.19\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i>, give intermittently in Sodium chloride 0.9%. Dilute in 200-500&#8239;mL infusion fluid; give over at least 2 hours; max. 4 hours between dilution and completion of administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36131\" outputclass=\"handlingAndStorage\" rev=\"1.8\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Handling and storage</title>\n<body>\n<section>\n<sectiondiv>\n<p>Owing to risk of contact sensitisation healthcare professionals should avoid contamination of hands.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1117-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/phenoxybenzamine-hydrochloride\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution, oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75512\" title=\"Capsule\" namespace=\"/drugs/phenoxybenzamine-hydrochloride/capsule\">Capsule</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78099\" namespace=\"/treatment-summaries/hypertension\" title=\"Hypertension\" count=\"1\" rel=\"backlink\">Hypertension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78218\" namespace=\"/treatment-summaries/beta-adrenoceptor-blocking-drugs\" title=\"Beta-adrenoceptor blocking drugs\" count=\"1\" rel=\"backlink\">Beta-adrenoceptor blocking drugs</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_834\" namespace=\"/interactions/list-of-drug-interactions/alpha-blockers/phenoxybenzamine\" title=\"Phenoxybenzamine\" count=\"1\" rel=\"link\">Phenoxybenzamine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75512\" namespace=\"/drugs/phenoxybenzamine-hydrochloride/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n</links>\n</topic>",
    "id": "PHP1117",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/phenoxybenzamine-hydrochloride",
    "basename": "phenoxybenzamine-hydrochloride",
    "title": "PHENOXYBENZAMINE HYDROCHLORIDE",
    "interactants": [
        {
            "id": "bnf_int_834",
            "label": "Phenoxybenzamine"
        }
    ],
    "vtmid": "74771007",
    "drugClassification": [
        "Alpha-adrenoceptor blockers"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Hypertension in phaeochromocytoma",
                        "html": "Hypertension in phaeochromocytoma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 10 mg daily, increased in steps of 10 mg daily until hypertension controlled or treatment not tolerated; maintenance 1&#8211;2 mg/kg daily in 2 divided doses.",
                        "html": "<p>Initially 10&#8239;mg daily, increased in steps of 10&#8239;mg daily until hypertension controlled or treatment not tolerated; maintenance 1&#8211;2&#8239;mg/kg daily in 2 divided doses.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Avoid infusion in hypovolaemia",
                "html": "Avoid infusion in hypovolaemia"
            },
            {
                "type": "contraindications",
                "textContent": "during recovery period after myocardial infarction (usually 3&#8211;4 weeks)",
                "html": "during recovery period after myocardial infarction (usually 3&#8211;4 weeks)"
            },
            {
                "type": "contraindications",
                "textContent": "history of cerebrovascular accident",
                "html": "history of cerebrovascular accident"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Avoid contact with skin (risk of contact sensitisation)",
                "html": "Avoid contact with skin (risk of contact sensitisation)"
            },
            {
                "type": "cautions",
                "textContent": "avoid extravasation (irritant to tissues)",
                "html": "avoid extravasation (irritant to tissues)"
            },
            {
                "type": "cautions",
                "textContent": "avoid in Acute porphyrias",
                "html": "avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "cautions",
                "textContent": "carcinogenic in animals",
                "html": "carcinogenic in <i>animals</i>"
            },
            {
                "type": "cautions",
                "textContent": "cerebrovascular disease",
                "html": "cerebrovascular disease"
            },
            {
                "type": "cautions",
                "textContent": "congestive heart failure",
                "html": "congestive heart failure"
            },
            {
                "type": "cautions",
                "textContent": "elderly",
                "html": "elderly"
            },
            {
                "type": "cautions",
                "textContent": "severe ischaemic heart disease",
                "html": "severe ischaemic heart disease"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Gastro-intestinal disturbances",
                        "html": "Gastro-intestinal disturbances",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Inhibition of ejaculation",
                        "html": "Inhibition of ejaculation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "lassitude",
                        "html": "lassitude",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "miosis",
                        "html": "miosis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nasal congestion",
                        "html": "nasal congestion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "postural hypotension (with dizziness and marked compensatory tachycardia)",
                        "html": "postural hypotension (with dizziness and marked compensatory tachycardia)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "rare": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "decreased sweating (after intravenous infusion)",
                        "html": "decreased sweating (after intravenous infusion)",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "dry mouth (after intravenous infusion)",
                        "html": "dry mouth (after intravenous infusion)",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "idiosyncratic profound hypotension (within few minutes of starting infusion)",
                        "html": "idiosyncratic profound hypotension (within few minutes of starting infusion)",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "convulsions (following rapid intravenous infusion)",
                        "html": "convulsions (following rapid intravenous infusion)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Hypotension may occur in newborn.",
                "html": "<p>Hypotension may occur in newborn.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "May be present in milk.",
                "html": "<p>May be present in milk.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution.",
                "html": "<p>Use with caution.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor blood pressure regularly during infusion.",
                "html": "<p>Monitor blood pressure regularly during infusion.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion, give intermittently in Sodium chloride 0.9%. Dilute in 200-500 mL infusion fluid; give over at least 2 hours; max. 4 hours between dilution and completion of administration.",
                "html": "<p>For <i>intravenous infusion</i>, give intermittently in Sodium chloride 0.9%. Dilute in 200-500&#8239;mL infusion fluid; give over at least 2 hours; max. 4 hours between dilution and completion of administration.</p>"
            }
        ]
    },
    "handlingAndStorage": {
        "handlingAndStorage": [
            {
                "type": "handlingAndStorage",
                "textContent": "Owing to risk of contact sensitisation healthcare professionals should avoid contamination of hands.",
                "html": "<p>Owing to risk of contact sensitisation healthcare professionals should avoid contamination of hands.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution",
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75512",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78099",
                "label": "Hypertension",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78218",
                "label": "Beta-adrenoceptor blocking drugs",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_834",
                "label": "Phenoxybenzamine",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75512",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    }
}